Prescriber Risks Ordering Semaglutide, Tirzepatide and Other Compounded GLP-1 Medications
(October 24, 2024): Semaglutide, tirzepatide and a slate of other GLP-1 receptor agonist medications have dominated weight loss headlines in recent years. Not surprisingly, many weight loss providers and clinics have refocused their approaches, incorporating these drugs into patient treatment regimens. Unfortunately, the popularity of these drugs has led to a variety of bad practices, […]
You must be logged in to post a comment.